(Q56773744)

1

object named as

Merit Cudkowicz

0 references

author name string

Michael E Bozik

2

0 references

Evan W Ingersoll

3

0 references

Robert Miller

4

0 references

Jeremy Shefner

6

0 references

Dan H Moore

7

0 references

David Schoenfeld

8

0 references

James L Mather

9

0 references

Donald Archibald

10

0 references

Mary Sullivan

11

0 references

Craig Amburgey

12

0 references

Juliet Moritz

13

0 references

Valentin K Gribkoff

https://scigraph.springernature.com/pub.10.1038/nm.2579

14

0 references

language of work or name

English

0 references

publication date

20 November 2011

0 references

published in

Nature Medicine

0 references

volume

17

0 references

page(s)

1652-1656

0 references

issue

12

0 references

exact match

0 references

cites work

Amyotrophic lateral sclerosis

1 reference

Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis

21 January 2018

1 reference

Mitochondrial dysfunction and amyotrophic lateral sclerosis

21 January 2018

1 reference

Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.

21 January 2018

1 reference

Mitochondrial dysfunction in neurodegenerative disorders.

21 January 2018

1 reference

Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction

21 January 2018

1 reference

Mitochondrial dysfunction and intracellular calcium dysregulation in ALS

21 January 2018

1 reference

Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui Farmaci.

21 January 2018

1 reference

KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.

21 January 2018

1 reference

R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.

21 January 2018

1 reference

Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects.

21 January 2018

1 reference

Toward more efficient clinical trials for amyotrophic lateral sclerosis

21 January 2018

1 reference

Selecting promising ALS therapies in clinical trials.

21 January 2018

1 reference

Outcome measures for early phase clinical trials.

21 January 2018

1 reference

Design of phase II ALS clinical trials.

21 January 2018

1 reference

Designing clinical trials in amyotrophic lateral sclerosis

21 January 2018

1 reference

Scrutinizing enrollment in ALS clinical trials: room for improvement?

21 January 2018

1 reference

Random-effects models for longitudinal data

21 January 2018

1 reference

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Clinical significance in the change of decline in ALSFRS-R

21 January 2018

1 reference

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

Phase II/III randomized trial of TCH346 in patients with ALS

21 January 2018

1 reference

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

21 January 2018

1 reference

The ALSFRSr predicts survival time in an ALS clinic population.

21 January 2018

1 reference

21 January 2018

1 reference

Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain.

21 January 2018

1 reference

Quality of life in ALS depends on factors other than strength and physical function.

21 January 2018

1 reference

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

21 January 2018

1 reference

Amyotrophic lateral sclerosis

21 January 2018

1 reference

[Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis]

21 January 2018

1 reference

12 December 2020

Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis

1 reference

12 December 2020

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review

1 reference

12 December 2020

ALSFRS-R score and its ratio: a useful predictor for ALS-progression

1 reference

12 December 2020

Combining mortality and longitudinal measures in clinical trials

1 reference

12 December 2020

Alternative trial design in amyotrophic lateral sclerosis saves time and patients

1 reference

12 December 2020

Trial of celecoxib in amyotrophic lateral sclerosis

1 reference

12 December 2020